Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events

Author:

Wu Feitong12,Jacobs David R.3,Daniels Stephen R.4,Kähönen Mika56,Woo Jessica G.7,Sinaiko Alan R.8,Viikari Jorma S. A.910,Bazzano Lydia A.11,Steinberger Julia12,Urbina Elaine M.13,Venn Alison J.14,Raitakari Olli T.15161718,Dwyer Terence141920,Juonala Markus910,Magnussen Costan G.11516

Affiliation:

1. Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

2. Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia

3. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis

4. Department of Pediatrics, University of Colorado School of Medicine, Children’s Hospital Colorado, Aurora

5. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

6. Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland

7. Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio

8. University of Minnesota Medical School, Minneapolis

9. Department of Medicine, University of Turku, Turku, Finland

10. Division of Medicine, Turku University Hospital, Turku, Finland

11. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana

12. Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis

13. The Heart Institute, Cincinnati Children’s Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio

14. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia

15. Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland

16. Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland

17. Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland

18. InFLAMES Research Flagship, University of Turku, Turku, Finland

19. Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, United Kingdom

20. Murdoch Children’s Research Institute, Melbourne, Victoria, Australia

Abstract

ImportanceElevated non–high-density lipoprotein cholesterol (non–HDL-C; a recommended measure of lipid-related cardiovascular risk) is common in children and increases risk of adult cardiovascular disease (CVD). Whether resolution of elevated childhood non–HDL-C levels by adulthood is associated with reduced risk of clinical CVD events is unknown.ObjectiveTo examine the associations of non–HDL-C status between childhood and adulthood with incident CVD events.Design, Setting, and ParticipantsIndividual participant data from 6 prospective cohorts of children (mean age at baseline, 10.7 years) in the US and Finland. Recruitment took place between 1970 and 1996, with a final follow-up in 2019.ExposuresChild (age 3-19 years) and adult (age 20-40 years) non–HDL-C age- and sex-specific z scores and categories according to clinical guideline–recommended cutoffs for dyslipidemia.Main Outcomes and MeasuresIncident fatal and nonfatal CVD events adjudicated by medical records.ResultsOver a mean length of follow-up of 8.9 years after age 40 years, 147 CVD events occurred among 5121 participants (60% women; 15% Black). Both childhood and adult non–HDL-C levels were associated with increased risk of CVD events (hazard ratio [HR], 1.42 [95% CI, 1.18-1.70] and HR, 1.50 [95% CI, 1.26-1.78] for a 1-unit increase in z score, respectively), but the association for childhood non–HDL-C was reduced when adjusted for adult levels (HR, 1.12 [95% CI, 0.89-1.41]). A complementary analysis showed that both childhood non–HDL-C levels and the change between childhood and adulthood were independently associated with the outcome, suggesting that from a preventive perspective, both childhood non–HDL-C levels and the change into adulthood are informative. Compared with those whose non-HDL-C levels remained within the guideline-recommended range in childhood and adulthood, participants who had incident non–HDL-C dyslipidemia from childhood to adulthood and those with persistent dyslipidemia had increased risks of CVD events (HR, 2.17 [95% CI, 1.00-4.69] and HR, 5.17 [95% CI, 2.80-9.56], respectively). Individuals who had dyslipidemic non–HDL-C in childhood but whose non-HDL-C levels were within the guideline-recommended range in adulthood did not have a significantly increased risk (HR, 1.13 [95% CI, 0.50-2.56]).Conclusions and RelevanceIndividuals with persistent non–HDL-C dyslipidemia from childhood to adulthood had an increased risk of CVD events, but those in whom dyslipidemic non–HDL-C levels resolve by adulthood have similar risk to individuals who were never dyslipidemic. These findings suggest that interventions to prevent and reduce elevated childhood non–HDL-C levels may help prevent premature CVD.

Publisher

American Medical Association (AMA)

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3